A sip for better sleep? beverage put to the test

NCT ID NCT07726719

Not yet recruiting Symptom relief Sponsor: Sirio Pharma Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether a concentrated beverage taken daily for 28 days can improve sleep quality in adults aged 18 to 60 with mild sleep issues. Participants keep sleep diaries and complete questionnaires on sleep quality and fatigue. The study uses a single-arm design, meaning everyone receives the beverage, and compares results before and after the trial period.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a functional food beverage (Ganmaidazao concentrated beverage)
What this could lead to: If it works, this could point toward a simple, non-drug option for improving sleep quality in people with mild sleep disturbances.
What could go wrong: This is a very small, early trial with only 25 participants and no placebo control, so results may not be reliable or generalizable. The beverage is a food product, so any sleep benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SLEEP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SLEEP

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.